Salmon migrate upstream against an opposing current in their natal river. However, the molecular mechanisms that stimulate upstream migratory behavior are poorly understood. Here, we show that 7α-hydroxypregnenolone (7α-OH PREG), a newly identified neuronal modulator of locomotion, acts as a key factor for upstream migration in salmon. We first identified 7α-OH PREG and cytochrome P450 7α-hydroxylase (P450 7α ), a steroidogenic enzyme producing 7α-OH PREG, in the salmon brain and then found that 7α-OH PREG synthesis in the brain increases during upstream migration. Subsequently, we demonstrated that 7α-OH PREG increases upstream migratory behavior of salmon. We further found that 7α-OH PREG acts on dopamine neurons in the magnocellular preoptic nucleus during upstream migration. Thus, 7α-OH PREG stimulates upstream migratory behavior through the dopaminergic system in salmon. These findings provide new insights into the molecular mechanisms of fish upstream migration.
Scientific RepoRts | 5:12546 | DOi: 10.1038/srep12546 modulator to increase locomotor activity in these vertebrates 17, 18, 20 . We further demonstrated that male newt brain exhibits marked seasonal changes in the synthesis of 7α -OH PREG and the expression of cytochrome P450 7α -hydroxylase (P450 7α ; gene name Cyp7b), a steroidogenic enzyme that catalyzes the formation of 7α -OH PREG from pregnenolone (PREG), and the maximum level occurs in the spring breeding period when locomotor activity of males increases 17, 19 . Based on these observations, we hypothesized that the brain of salmon actively produces 7α -OH PREG, a neuronal modulator to stimulate locomotion, just before and during upstream migration to reach their spawning grounds.
To test our hypothesis, we conducted a series of experiments using adult chum salmon, Oncorhynchus keta. First, we identified 7α -OH PREG and P450 7α that catalyzes the formation of 7α -OH PREG in the salmon brain. Subsequently, we detected marked changes in 7α -OH PREG synthesis and concentration, and Cyp7b mRNA expression in the salmon brain during homing migration that comprises upstream migration. To investigate whether 7α -OH PREG is involved in upstream migration in the salmon, aminoglutethimide (AG), an inhibitor of cytochrome P450 side-chain cleavage enzyme (P450scc; gene name Cyp11a) that catalyzes the formation of PREG, a precursor of 7α -OH PREG, was intracerebroventricularly (icv) injected into the brain of salmon just prior to upstream migration for behavioral testing. 7α -OH PREG was also injected icv into the brain of AG-treated salmon for behavioral testing. To clarify the molecular mechanisms of 7α -OH PREG action on upstream migration, we further investigated the effect of central administration of 7α -OH PREG on dopamine concentration in the salmon brain. Finally, to better understanding the mode of 7α -OH PREG action on upstream migration of salmon, we investigated the localization of P450 7α and tyrosine hydroxylase (TH), a marker for dopamine neurons, in the salmon brain. This study provides new insights into the molecular mechanisms that underlie upstream migratory behavior in salmon from a novel standpoint.
Results
Identification of 7α-OH PREG in the salmon brain. First, we identified a previously undescribed fish neurosteroid from the brain of chum salmon by using biochemical techniques combined with high-performance liquid chromatography (HPLC) and gas chromatography/mass spectrometry (GC-MS) analyses. The initial finding was that an unknown fish neurosteroid was metabolized from PREG in the salmon brain. Salmon brain homogenates were incubated with tritiated PREG as a precursor, and radioactive metabolites were analyzed by reversed-phase HPLC. A major radioactive peak of the metabolite was detected approximately 18 min before the elution of PREG (Fig. 1a) . In addition, some small radioactive peaks corresponding to progesterone (PROG) and testosterone (T) were also detected (Fig. 1a) . Several nonradioactive steroids were used as reference standards for HPLC analysis, and 7α -OH PREG and its stereoisomer 7β -OH PREG exhibited the same retention time as the radioactive peak under a similar chromatographic condition (Fig. 1a) . The radioactive metabolite corresponding to 7α -and 7β -OH PREG increased in a time-dependent manner (Fig. 1a) , and the inhibitor of P450s, ketoconazole (10 −4 M), reduced the metabolite (Fig. 1a) . The metabolite of PREG was analyzed further by GC-MS. Trimethylsilyl ether derivatives of the authentic 7α -and 7β -OH PREG and the metabolite obtained from nonradioactive PREG were prepared and used in the GC-MS analysis. Based on GC-selected ion monitoring (SIM) analysis [mass/charge (m/z) 386], the metabolite had a retention time which was identical to 7α -OH PREG (18.3 min; Fig. 1b) . Thus, the unknown fish neurosteroid converted from PREG in the salmon brain was identified as 7α -OH PREG (Fig. 1h) .
Identification of salmon P450 7α , a steroidogenic enzyme producing 7α-OH PREG, and demonstration of its enzymatic activity in the salmon brain. To determine the mode of 7α -OH PREG synthesis, we identified a cDNA from brain tissue encoding a putative chum salmon P450 7α (gene name Cyp7b), a steroidogenic enzyme that produces 7α -OH PREG from PREG. A combination of 3′ -and 5′ -RACE produced a sequence, which we then compared with those of newt, quail, mouse and human Cyp7b 18, 19, 23, 24 . The identified putative salmon Cyp7b cDNA had a full length of 2,908 bp ( Supplementary  Fig. S1 ). The putative salmon Cyp7b open reading frame started with a methionine at nucleotide 74 and terminated with a TGA codon at nucleotide 1,565, which encoded a protein of 497 amino acids ( Supplementary Fig. S1 ). The deduced amino acid sequence of the open reading frame (497 amino acids) shared 52%, 53%, 43% and 47% identities with newt, quail, mouse and human Cyp7b, respectively. The putative salmon Cyp7b contained a highly conserved motif, FXXGXXXCXG(XXXA) of Cyps 25 (see double underlining in Supplementary Fig. S1 ), which is thought to represent the heme-binding site with the arrangement of amino acids around the cysteine residue postulated to preserve the three-dimensional structure of this region for ligand binding 26 . Another domain (see underlining in Supplementary Fig.  S1 ), which may be conserved in Cyps and is responsible for steroid interconversions 27, 28 , also featured in salmon Cyp7b.
After the identification of salmon Cyp7b cDNA, we demonstrated the enzymatic activity of this putative salmon P450 7α . The homogenate of COS-7 cells transfected with the putative salmon Cyp7b cDNA converted PREG to 7α -OH PREG by HPLC analysis (Fig. 1c) , whereas the inhibitor of P450s, ketoconazole (10 −4 M), reduced this metabolic process (Fig. 1d) . COS-7 cells that were not transfected with the putative salmon Cyp7b cDNA did not convert PREG to 7α -OH PREG (Fig. 1e) . Subsequently, 7α -OH PREG synthesis was confirmed by GC-MS analysis. The homogenate of COS-7 cells transfected with the putative salmon Cyp7b cDNA produced a metabolite that had the same retention time as 7α -OH PREG characterized by GC-SIM trace (Fig. 1f) . COS-7 cells without transfection of the putative salmon Cyp7b cDNA did not convert PREG to 7α -OH PREG (Fig. 1g) . It has been reported that the salmon brain expresses P450scc that catalyzes the formation of PREG from cholesterol 29 . Thus, the salmon brain expresses not only P450scc but also P450 7α , and produces 7α -OH PREG from cholesterol via PREG (Fig. 1h) .
Changes in 7α-OH PREG synthesis and concentration, and Cyp7b mRNA expression in the salmon brain during homing migration. To understand the physiological role of 7α -OH PREG during upstream migration, we examined changes in 7α -OH PREG synthesis and concentration, and Cyp7b mRNA expression in the salmon brain during homing migration that comprises upstream migration. Sexually mature adult chum salmon were collected from the Bering Sea to the Chitose salmon hatchery, Hokkaido, Japan during their homing migration (Fig. 2a,b) . Fish of both sexes were captured from (i) the Bering Sea at the beginning of homing migration; (ii) the Ishikari Bay, the entrance of upstream migration just prior to upstream migration; (iii) the pre-spawning ground during upstream migration; and (iv) the Chitose salmon hatchery, the goal of upstream migration just after upstream migration (Fig. 2a,b) . As shown in Fig. 2c , Cyp7b mRNA expression in the salmon brain of both sexes markedly changed at these different places during homing migration. Cyp7b mRNA was highly expressed in the brain of both sexes from the Ishikari Bay to the Chitose salmon hatchery compared with the Bering Sea (Fig. 2c) . Similar changes in 7α -OH PREG synthesis in the brain of both sexes were detected (Fig. 2d) . 7α -OH PREG concentration in the brain of both sexes also increased from the Ishikari Bay to the pre-spawning ground (Fig. 2e) . However, 7α -OH PREG concentration in the brain was low at the Chitose salmon hatchery (Fig. 2e) . These results indicate that 7α -OH PREG synthesis and concentration, and Cyp7b mRNA expression in the salmon brain increase just before and during upstream migration. In contrast to the brain, we did not detect a significant level of 7α -OH PREG in the plasma from the Bering Sea to the Chitose salmon hatchery during homing migration (Supplementary Fig. S2 ). We further examined changes in the concentrations of PREG, a precursor of 7α -OH PREG ( Supplementary Fig. S3a ), and PROG, another metabolite of PREG ( Supplementary Fig. S3a ), in the brain of salmon during homing migration. PREG concentration in the brain did not change significantly from the Bering Sea to the pre-spawning ground and decreased at the Chitose salmon hatchery ( Supplementary Fig. S3b ). PROG concentration in the brain did not show any statistically significant change at different places during homing migration ( Supplementary Fig. S3c ).
Reduction of upstream migration by inhibiting 7α-OH PREG synthesis and induction of upstream migration by 7α-OH PREG administration in salmon.
To investigate whether 7α -OH PREG is involved in the stimulation of upstream migratory behavior, 7α -OH PREG was manipulated in the brain of chum salmon captured at the Ishikari Bay just prior to upstream migration and subsequently behavioral analyses were conducted in an artificial river (see Methods). The number of fish that stayed in the upstream arm (upstream migratory behavior) or the pool (no migratory behavior) was counted and expressed as a percentage of the total number of fish in each group (Fig. 3a) . As shown in Fig. 2 , salmon at the Ishikari Bay showed high levels of 7α -OH PREG synthesis and concentration in the brain. To reduce the synthesis of 7α -OH PREG in the salmon brain, AG, an inhibitor of P450scc that catalyzes the formation of PREG, a precursor of 7α -PH PREG ( Fig. 1h and Supplementary Fig. S3a ), was injected icv into salmon. In the control group, the number of fish that exhibited upstream migratory behavior was almost half that of fish that were injected with icv vehicle (0.9% saline; Fig. 3a) . However, icv injection of AG significantly (P < 0.05) decreased the number of fish that exhibited upstream migratory behavior and increased the number of fish that exhibited no migratory behavior (Fig. 3a) . Thus, the number of fish exhibiting upstream migratory behavior was significantly (P < 0.05) lower than that of fish exhibiting no migratory behavior in the AG-treated group (Fig. 3a) . By contrast, icv injection of 7α -OH PREG into AG-treated fish restored the number of fish that exhibited upstream migratory behavior (Fig. 3a) . 7α -OH PREG concentration in the brain was decreased significantly (P < 0.05) by icv administration of AG, whereas this decrease in 7α -OH PREG concentration in the brain was restored significantly (P < 0.05) Figure 3 . Effects of icv injection of AG or AG plus 7α-OH PREG on upstream migratory behavior of chum salmon Oncorhynchus keta, and 7α-OH PREG concentration in the salmon brain. Salmon of both sexes captured at the Ishikari Bay just prior to upstream migration were used and behavioral testing was conducted in an artificial river that consisted of upstream arm and pool. A gate prevented the test fish from entering the upstream arm. After the acclimation period, the gate was opened, and the water flow was introduced to the inlet of the arm for a 9-h period. Fish were allowed to move freely. The number of fish that stayed in the upstream arm (upstream migratory behavior) or the pool (no migratory behavior) was counted and expressed as a percentage of the total number of fish in each group. by icv co-administration of AG and 7α -OH PREG (Fig. 3b) . These results indicate that 7α -OH PREG in the brain is important to stimulate upstream migratory behavior in this species.
Comparisons of Cyp7b mRNA expression and 7α-OH PREG synthesis among different brain regions in salmon during upstream migration. Data on the region-specific synthesis of 7α -OH PREG are required to understand the mode of action of this neurosteroid on upstream migratory behavior of salmon. Therefore, we compared the expression of Cyp7b mRNA and the synthesis of 7α -OH PREG among different brain regions of salmon captured at the pre-spawning ground during upstream migration. The salmon brain was subdivided into six regions: olfactory bulb, telencephalon, optic tectum, hypothalamus, cerebellum and medulla oblongata. As shown in Fig. 4a ,b, Cyp7b mRNA expression and 7α -OH PREG synthesis were detected in all areas of the brain, but there were clear regional differences. The highest levels of Cyp7b mRNA expression and 7α -OH PREG synthesis were found in the optic tectum and hypothalamus compared to other brain regions, such as the olfactory bulb, telencephalon, cerebellum and medulla oblongata (Fig. 4a,b) . Cyp7b mRNA expression and 7α -OH PREG synthesis in the pituitary gland were low in salmon during upstream migration (Fig. 4a,b) .
Enhancement of dopamine concentration by 7α-OH PREG administration in the salmon brain.
We previously found that 7α -OH PREG increases the concentration of dopamine in the telencephalic region by acting on dopamine neurons localized in the diencephalic region in newts and quail 17, 18 . Therefore, we next investigated whether dopamine concentration was altered by 7α -OH PREG in the brain of salmon captured at the Ishikari Bay just prior to upstream migration. AG-injected salmon had decreased telencephalic dopamine concentrations compared to the control group (P < 0.05; Fig. 5a ). In addition, icv injection of 7α -OH PREG to AG-treated salmon increased dopamine concentration in the telencephalon compared with AG-treated salmon (P < 0.05; Fig. 5a ). In contrast, 7α -OH PREG manipulation had no effect on hypothalamic dopamine concentrations (Fig. 5b) . In addition, we compared the concentration of dopamine in the brain of salmon at the pre-spawning ground during upstream migration and the Bering Sea at the beginning homing migration. Telencephalic dopamine concentrations at the pre-spawning ground were much higher than that at the Bering Sea (Fig. 5c) . In contrast to the telencephalon, hypothalamic dopamine concentrations did not show any statistically significant differences (Fig. 5d) .
Localization of P450 7α and TH in the salmon brain during upstream migration. Immuno- histochemical (IHC) analysis using anti-salmon P450 7α antibody was conducted to localize P450 7α in the brain of salmon at the pre-spawning ground during upstream migration. To confirm that this antibody Supplementary Fig. S4 ). This band disappeared when the antibody was preabsorbed with salmon P450 7α protein (10 μ g/ml; Supplementary Fig. S4 ).
In the olfactory bulb, immunoreactive cells were observed in the internal cell layer (ICL). In the telencephalon, immunoreactive cells were observed in the dorsal nucleus (Vd) and ventral nucleus (Vv) of the ventral telencephalic area. In the optic tectum, a large number of immunoreactive cells were observed in the stratum album central (SAC). An intense expression of P450 7α protein was detected in several hypothalamic regions. Clusters of the cells expressing P450 7α protein were localized in the following restricted regions in the hypothalamus: the magnocellular preoptic nucleus (PM; Fig. 5e ), oculomotor nucleus (III), nucleus lateralis valvulae (NLV), and molecular layer (ML). In the cerebellum and medulla oblongata, some immunoreactive cells were detected in the medial longitudinal fascicle (mlf) and central gray (CG). No immunostained cell was observed when the anti-salmon P450 7α antibody was preabsorbed with salmon P450 7α protein (10 μ g/ml; Fig. 5f ).
To determine the mode of action of 7α -OH PREG on upstream migratory behavior, we further investigated the expression of tyrosine hydroxylase (TH), a marker for dopamine neurons, around the P450 7α -expressing cells in the brain of salmon at the pre-spawning ground during upstream migration. Double immunolabeling showed that TH and P450 7α were expressed in two distinct cell populations that were close to each other in PM cells in the hypothalamus (Fig. 5h) . TH immunoreactive fibers were also observed in the PM (Fig. 5g) .
Discussion
In this study, we first identified 7α -OH PREG in the salmon brain. Subsequently, we found that salmon brain expresses P450 7α , a steroidogenic enzyme producing 7α -OH PREG from PREG. The expression of P450scc that produces PREG from cholesterol has been demonstrated in the salmon brain 29 . Taken together, it appears that the salmon brain produces 7α -OH PREG from cholesterol via PREG. Because salmon migrate upstream against an opposing current in their natal river [3] [4] [5] [6] , high locomotor activity is required to complete upstream migration in salmon. Therefore, our aim in this study was to demonstrate that 7α -OH PREG, a neuronal modulator of locomotion, stimulates upstream migration in salmon.
We hypothesized that 7α -OH PREG is produced actively in the brain of salmon just before and during upstream migration. To test this hypothesis, we investigated changes in 7α -OH PREG synthesis and concentration, and Cyp7b mRNA expression in the salmon brain during homing migration comprising upstream migration. The synthesis and concentration of 7α -OH PREG in the brain were low in salmon at the Bering Sea at the beginning of homing migration and high in salmon at the Ishikari Bay just prior to upstream migration and the pre-spawning ground during upstream migration. In addition, similar changes in the expression of Cyp7b mRNA were evident in the salmon brain. In contrast, the concentrations of PREG, a precursor of 7α -OH PREG, and PROG, another metabolite of PREG, did not change in the brain of salmon from the Bering Sea to the pre-spawning ground. These results suggest that 7α -OH PREG plays an important role in the salmon brain to stimulate upstream migratory behavior during upstream migration.
Cyp7b mRNA expression and 7α -OH PREG synthesis were high in the brain from the Ishikari Bay to the Chitose salmon hatchery compared with the Bering Sea. 7α -OH PREG concentration in the brain also increased from the Ishikari Bay to the pre-spawning ground. However, 7α -OH PREG concentration in the brain decreased at the Chitose salmon hatchery. This discrepancy may be because the concentration of PREG, precursor of 7α -OH PREG, had decreased in the brain at the Chitose salmon hatchery ( Supplementary Fig. S3b ), resulting in low production of 7α -OH PREG, although Cyp7b mRNA expression and 7α -OH PREG synthetic activity were high in the brain at the Chitose salmon hatchery.
According to our previous study in newts, the synthesis and concentration of 7α -OH PREG changes during the annual breeding cycle, with a maximum level in the spring breeding period when locomotor activity increases 17, 19, 30 . In addition, we also reported that 7α -OH PREG is involved in enhancing the expression of sexual behavior of newts during the spring breeding period when locomotor activity increases 31 . To demonstrate the stimulatory action of 7α -OH PREG on upstream migratory behavior in salmon, 7α -OH PREG was manipulated in the brain of salmon captured at the Ishikari Bay just prior to upstream migration and behavioral analyses were conducted in an artificial river. We found that the inhibition of 7α -OH PREG synthesis in the brain by AG administration reduced the number of salmon that exhibited upstream migratory behavior. By contrast, 7α -OH PREG administration to AG-treated salmon rescued this behavior. These behavioral changes depended on changes in the 7α -OH PREG levels in the brain. Accordingly, 7α -OH PREG in the brain is possible to stimulate upstream migration of salmon to reach their spawning grounds. Because AG is an inhibitor of P450scc, administration of AG decreases not only 7α -OH PREG but also PREG and PROG. Our findings suggest that PREG and PROG in the salmon brain may not underlie upstream migration, as levels did not change in salmon from the Bering Sea to their pre-spawning ground. In addition to 7α -OH PREG, allopregnanolone (ALLO), a metabolite of PROG, is also known as a stimulator of locomotor activity in mammals 32, 33 . ALLO is synthesized in the brain of teleost fish 34, 35 . To reveal the detailed molecular mechanisms of upstream migration in salmon, we need to perform further experiments to clarify the action of ALLO on upstream migration. To understand the mode of action of 7α -OH PREG during upstream migration, we first investigated the region-specific 7α -OH PREG synthesis and P450 7α expression in the salmon brain during upstream migration. The levels of 7α -OH PREG synthesis in the hypothalamus and optic tectum were higher than those in other brain regions, such as the olfactory bulb, telencephalon, cerebellum and medulla oblongata. P450 7α -positive cells were localized mainly in the PM, III, NLV and ML in the hypothalamus and the SAC in the optic tectum. It is well known that neurosteroids are produced in neurons and glial cells in the brain in mammals, birds and amphibians [10] [11] [12] [13] [14] [15] [16] . In teleost fish, mRNAs of steroidogenic enzymes, P450scc, 3β -hydroxysteroid dehydrogenase/Δ 5 -Δ 4 -isomerase (3β -HSD; gene name Hsd3b), cytochrome P450 17α -hydroxylase/c17,20-lyase (P450 17α,lyase ; gene name Cyp17), cytochrome P450 aromatase A (P450aromA; gene name Cyp19a) and P450aromB (gene name Cyp19b), are mainly expressed in radial glial cells 34, 35 . In addition, in fish it is thought that P450aromB-expressing radial glial cells are neural progenitor [36] [37] [38] . According to Diotel et al., radial glial cells are brain stem cells through the entire lifespan of fish, and it is suggested that some neurosteroids are implicated in this neurogenic process 34, 35 . Additional studies are needed to elucidate the cell type of P450 7α -expressing cells and the other function(s) of 7α -OH PREG in the brain of teleost fish.
Further investigation into the effect of 7α -OH PREG on dopamine neurons revealed that AG administration decreased dopamine concentration in the telencephalon, whereas 7α -OH PREG administration to AG-treated salmon rescued dopamine concentration in this brain region. In contrast, the hypothalamus showed no statistically significant change in dopamine concentration by 7α -OH PREG manipulation. Together these results indicate that 7α -OH PREG increases the release of dopamine in the telencephalon during upstream migration to induce upstream migratory behavior. In addition, P450 7α and TH were expressed in two distinct cell populations that were close to each other in PM cells in the hypothalamus, indicating that 7α -OH PREG may have a paracrine action on dopamine neurons in the PM. The coordinated action of several neurosteroidogenic enzymes is essential for understanding of neurosteroidogenesis. As for the production of 7α -OH PREG, the coordinated action of P450scc and P450 7α is required. Previous studies demonstrated that the brains of teleost fish express P450scc, and produces PREG, the precursor of 7α -OH PREG 29, 34, 35 . In situ hybridization showed that P450scc-positive cells were located in the PM 34, 35 . Because the PM expressed P450 7α , this nucleus may be the sites of 7α -OH PREG formation from cholesterol in the salmon brain.
It has been reported that dopaminergic neurons are localized in the hypothalamic region, and that they project into the telencephalic region in many vertebrates including fish and birds [39] [40] [41] . Here we have reported that 7α -OH PREG increases dopamine concentration in the telencephalic region 17 , which is known to be involved in the stimulation of locomotor behavior in vertebrates including fish [42] [43] [44] [45] . Thus, 7α -OH PREG actively synthesized in the hypothalamus may act on dopamine neurons in the PM to induce dopamine release from their termini in the telencephalon and consequently stimulate upstream migratory behavior in salmon. Our previous study showed that the effect of 7α -OH PREG on locomotion is mediated by dopamine D 2 -like receptor in newts 17 . In addition, it has been reported that the role of the dopaminergic system in the stimulation of locomotor activity is mediated by dopamine D 2 -like receptor in the telencephalon in various vertebrates including fish [46] [47] [48] [49] . These previous findings are in agreement with the present findings indicating that 7α -OH PREG stimulates upstream migratory behavior of salmon by means of the dopaminergic system. 
Methods

Animals. Adult chum salmon
Identification of 7α-OH PREG by biochemical analyses combined with HPLC and GC-MS.
To identify a previously undescribed fish neurosteroid produced from PREG in the salmon brain, the radioactive metabolite of [ 3 H]PREG (specific activity, 14 Ci/mmol (1 Ci = 37 GBq); PerkinElmer) was analyzed by HPLC using brain homogenates as described previously [17] [18] [19] 22 . In brief, brain homogenates containing 200 mg of tissue from salmon were incubated in PBS containing 1 million cpm [ 3 H]PREG, 0.24 mM NADPH, and 4% propylene glycol for 60 min at 25 °C. After incubation, steroids were extracted by ethyl acetate and subjected to HPLC analysis by using a reversed-phase column, LiChrospher 100 RP-18 (4.0 mm × 250 mm, Kanto). The column was eluted with a 30-min linear gradient of 40-70% acetonitrile at a flow rate of 0.7 ml/min, followed by an isocratic elution of 70% acetonitrile. The eluate was fractionated and counted in a flow scintillation analyzer (Radiomatic 525TR; PerkinElmer). To confirm the involvement of steroidogenic enzyme in the formation of the unknown fish neurosteroid, brain homogenates and [
3 H]PREG were incubated with ketoconazole (Sigma-Aldrich), an inhibitor of cytochrome P450s, at a final concentration of 10 −4 M. The unknown fish neurosteroid was further examined in GC-SIM analysis as described previously [17] [18] [19] 21, 22 . In brief, 500 mg of salmon brain tissue was homogenized in 1 ml methanol/H 2 O (75:25; vol/vol) on ice. The homogenate was loaded on a C18 cartridge, and the steroid fraction was eluted with methanol and evaporated to dryness. Trimethylsilyl ether derivatives of the steroid fraction were prepared before GC-MS by reacting the dried sample with bis(trimethylsilyl)trifluoroacetamide (Wako Pure Chemical) at 60 °C for 30 min. For the identification of this unknown neurosteroid, a GC-MS system (GCMS-QP5000, Shimadzu) equipped with a CP-Sil 5CB capillary column (0.25 mm × 30 m, Varian) was used as previously described [17] [18] [19] 21, 22 . The column was maintained at 220 °C for 5 min, and then the temperature was raised to 300 °C at the rate of 5 °C/min. These biochemical analyses were repeated independently at least four times. Both 7α -OH PREG and its stereoisomer 7β -OH PREG, which were used as reference standards in these analyses, were purchased from Steraloids.
Salmon Cyp7b cDNA cloning. Partial salmon Cyp7b cDNA was obtained from salmon brain cDNA by nested PCR using degenerate primers. The primers used for the PCR were as follows: sense primer 1, 5′ -AGGAGASCTGGKGAGCCNCC-3′ (identical to nucleotides 148-168; GenBank accession no. AB824841), and antisense primer 1, 5′ -CCAAYTGTTCTCTGGTGARG-3′ (complementary to nucleotides 1057-1076; GenBank accession no. AB824841). These PCR primers were designed on the basis of alignment of newt Cyp7b (AB374535), quail Cyp7b (AB329632), mouse Cyp7b (NM_007825) and human Cyp7b (NM_004820) mRNA sequences. The unknown sequences of 5′ -and 3′ -untranslated regions were analyzed by rapid amplification of cDNA ends methods as previously described 19, 21 with salmon Cyp7b-specific primers as follows: sense primer 2, 5′ -TTCTGGGCMATGTATTATCTGC-3′ (identical to nucleotides 941-962; GenBank accession no. AB824841), sense primer 3, 5′ -AGACCTCACCTTCACCAGAG-3′ (identical to nucleotides 1048-1067; GenBank accession no. AB824841), antisense primer 2, 5′ -CTCCACTCGCTCTCCCCAGTAAGG-3′ (complementary to nucleotides 541-564; GenBank accession no. AB824841), and antisense primer 3, 5′ -GATGACGTACGGATACAGCAACGG-3′ (complementary to nucleotides 314-337; GenBank accession no. AB824841).
Enzymatic activity of salmon Cyp7b transfected in COS-7 cells. COS-7 cells were transfected with the putative salmon Cyp7b as described previously 18, 19 to assess its enzymatic activity. The full-length open reading frame of the putative salmon Cyp7b was amplified from salmon brain cDNA using the forward primer 5′ -GCCGCCACCATGTTAGAGTTTGTTTTACC-3′ and the reverse primer 5′ -TCAGGATCGACGTAGCCTGT-3′ and subcloned into the mammalian expression vector pcDNA3.1/ V5-His-TOPO (Thermo Fisher Scientific). Positive colonies were selected and subcultured, and the plasmid DNAs were purified by the Wizard plus SV minipreps DNA purification system (Promega). COS-7 cells were supplied from Riken Cell Bank (Tsukuba, Japan) and maintained in DMEM (Sigma-Aldrich) supplemented with 10% (vol/vol) fetal bovine serum, penicillin (50 U/ml), streptomycin (50 μ g/ml), and HEPES (10 mM, pH 7.4). Transfection was performed with the Lipofectamine 2000 (Thermo Fisher Scientific) as described previously 18, 19 . After transfection, the cells were harvested, centrifuged (10,000 × g for 5 min at 4 °C), and stored at -80 °C. The cell homogenates were incubated with 1 million cpm of [ 3 H] PREG for HPLC analysis or nonradioactive PREG for GC-MS analysis as described previously 18, 19 . To confirm the enzymatic activity of the putative salmon P450 7α , the cell homogenates and [
3 H]PREG were incubated with ketoconazole (Sigma-Aldrich), an inhibitor of P450s, at a final concentration of 10 −4 M.
Quantification of Cyp7b mRNA expression by real-time PCR.
To measure the expression of Cyp7b mRNA in the salmon brain of both sexes during homing migration, real-time PCR was conducted by using the StepOnePlus system (Applied Biosystems) as described previously 22 . The PCR primers used for the amplification of salmon Cyp7b cDNA fragments were 5′ -GCGGTGAATGAGATAAAGCAGTT-3′ (identical to nucleotides 1403-1425; GenBank accession no. AB824841) and 5′ -CCTGTAGCGGATCTGGACATC-3′ (complementary to nucleotides 1532-1552; GenBank accession no. AB824841). The PCR primers for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were 5′ -CAGCAATGCTTCATGCACAA-3′ (identical to nucleotides 508-527; GenBank accession no. NM_001123561) and 5′ -CTCCACAGCTTTCCAGAAGGA-3′ (complementary to nucleotides 637-657; GenBank accession no. NM_001123561). Gapdh was used as the internal standard. The reaction mixture contained SYBR Green Real-Time PCR Mix (Toyobo), 400 nM each of forward and reverse primers, and 30 ng of cDNA in a final volume of 20 μ l. PCR was run with a standard cycling program, 95 °C for 3 min, 40 cycles of 95 °C, 15 s; 60 °C, 15 s; and 72 °C, 15 s. An external standard curve was generated by a serial 10-fold dilution of cDNA obtained from the salmon brain, which had been purified, and its concentration was measured. To confirm the specificity of the amplification, the PCR products were subjected to a melting curve analysis and gel electrophoresis. The results were normalized to the expression of gapdh using the StepOnePlus 2.0 software (Applied Biosystems). Quantification of 7α-OH PREG synthesis by HPLC analysis. To measure the synthesis of 7α -OH PREG in the salmon brain of both sexes during homing migration, HPLC analysis was conducted as described previously [17] [18] [19] 21, 22 . Each homogenate containing 200 mg of the tissue was incubated separately with [ 3 H]PREG for 60 min at 25 °C. After incubation, the extracted steroids were subjected to HPLC analysis.
Quantification of 7α-OH PREG concentration by GC-SIM analysis.
To measure the concentration of 7α -OH PREG in the salmon brain of both sexes during homing migration, GC-SIM analysis was conducted as described previously [17] [18] [19] 21, 22 . The extracted steroids derived from brain samples (500 mg tissue each) were applied to GC-SIM analysis. The concentration of 7α -OH PREG in the plasma of male salmon during homing migration was also measured by GC-SIM analysis [17] [18] [19] 21, 22 . Plasma samples (500 μ l each) were used for GC-SIM analysis.
Quantification of PREG and PROG concentrations by EIA. To measure the concentrations of PREG and PROG in the brain of male salmon during homing migration, the enzyme immunoassays (EIAs) were conducted as described previously 21 . In brief, 100 mg of salmon brain tissue was homogenized in 1 ml methanol/H 2 O (75:25; vol/vol) on ice. The homogenate was loaded on a C18 cartridge, and the steroid fraction was eluted with methanol and evaporated to dryness. The dried samples were dissolved in 500 μ l EIA buffer containing 1% propylene glycol and vortexed for 10 min 21 . Each aqueous solution was divided into two aliquots for the measurements of PREG and PROG. PREG and PROG concentrations were assayed by using a pregnenolone EIA kit (Cayman Chemical) and a progesterone EIA kit (IBL), respectively.
7α-OH PREG manipulation and behavioral analyses.
To investigate whether 7α -OH PREG is involved in the stimulation of upstream migratory behavior, 7α -OH PREG manipulation and behavioral analyses were conducted in September-November of 2010-2011 at the Toya lake station, Hokkaido University, Japan. Fish were collected just prior to upstream migration by set nets at the Ishikari Bay and subsequently transferred to the Toya lake station. A total of 45 fish of both sexes [FL: 65.00 ± 3.16 cm; BW: 3.01 ± 0.66 kg; GSI: 3.13 ± 0.67 in male and 18.12 ± 5.59 in female] were divided into 3 groups; vehicle (0.9% saline)-injected group (control group), AG-injected group (AG group) and AG plus 7α -OH PREG-injected group (AG plus 7α -OH PREG group). Each treatment solution (5 μ l) was injected ICV into the brain of salmon through 0.3-mm diameter cannula that was implanted at the junction of the parietal and frontal bones in the cranial midline under anesthesia (0.005% clove oil; Wako Pure Chemical). AG (3 μ g/5 μ l) was injected 3 times every other day for 6 days (AG group), and then 7α -OH PREG (100 ng/ 5 μ l) was injected one time (AG plus 7α -OH PREG group). Control salmon were injected with an equal volume of vehicle (0.9% saline).
Behavioral analyses were conducted in an artificial river that consisted of upstream arm (12 m × 0.6 m, 0.6 m water depth) and pool (3 m × 1.8 m, 0.6 m water depth) with an outlet at the end as described previously 50, 51 . Before behavioral analyses, the test fish were kept for acclimation for 3 h in the pool. A gate prevented the test fish from entering the upstream arm. After the acclimation period, the gate was opened, and the water flow at 50 l/s was introduced to the inlet of the arm for a 9-h period. Behavioral testing was conducted between 7 pm and 4 am to avoid the influence of light intensity and the fish were allowed to move freely. The number of fish that stayed in the upstream arm (upstream migratory behavior) or the pool (no migratory behavior) was counted at the end of trial (4 am) and expressed as a percentage of the total number of fish in each group.
Measurement of dopamine concentration by HPLC analysis.
To investigate whether dopamine concentrations were altered by 7α -OH PREG in the salmon brain of both sexes, dopamine concentrations in the telencephalon and hypothalamus of salmon captured at the Ishikari Bay just prior to upstream migration were measured after behavioral analyses by HPLC-ECD (ECD-300, Eicom) as described previously 17, 21 . Telencephalic and hypothalamic tissues (100 mg each) of salmon treated by vehicle alone, AG or AG plus 7α -OH PREG were homogenized in 0.2 M perchloric acid, maintained on ice for 30 min, and centrifuged at 15,000 × g for 15 min, and dopamine concentrations in the supernatant were measured. The concentrations of dopamine in the telencephalic and hypothalamic tissues were also measured at the Bering Sea at the beginning homing migration and the pre-spawning ground during upstream migration.
Production of salmon P450 7α antibody. A synthetic oligopeptide corresponding to the 486-497 amino acid sequence of salmon Cyp7b (SDVQIRYRLRRS; GenBank accession no. AB824841) was produced as described previously 19 . For antibody production, keyhole limpet hemocyanin (Sigma-Aldrich) was coupled to the cysteine residues at the N-terminus of the synthetic oligopeptide by use of m-maleimidobenzoyl-N-hydroxysuccinimide ester (Sigma-Aldrich). Antibody against the oligopeptide of salmon P450 7α was generated in a rabbit by means of the lymph node injection technique 52 . For immunization, 100 μ g hemocyanin-conjugated oligopeptide was dissolved in 100 μ l saline, emulsified with an equal volume of Freund's complete adjuvant (Dibco), and injected under Nembutal anesthesia. Starting two weeks after the first injection, four subcutaneous injections (100 μ g each) were given in multi-sites on the dorsal surface of the rabbit every two weeks. Two weeks after the last injection, the rabbit was bled from the carotid artery and the serum was separated by centrifugation.
To confirm that this antibody recognized the appropriate antigen, Western blot analysis was performed on extract of COS-7 cells transfected with salmon Cyp7b cDNA as described above. The extract of COS-7 cells transfected with salmon Cyp7b cDNA were separated on a 12.5% SDS-polyacrylamide gel under reducing conditions and transferred to PVDF membranes (Hybond-P; GE Healthcare). The membrane was incubated with anti-salmon P450 7α antibody at 4 °C overnight and then for 1 h with goat-anti-rabbit IgG-horseradish-peroxidase conjugate diluted 1:1,000. An intense immunoreactive band was detected by using ECL prime Western blotting detection system (GE Healthcare). To control the specificity of the immunoreactive band, the primary antibody preabsorbed with the salmon P450 7α protein (10 μ g/ml) was used.
Immunohistochemical (IHC) staining with P450 7α antibody. IHC localization of P450 7α was performed as described previously 19, 21, 22 . In brief, chum salmon captured at their pre-spawning ground during upstream migration were terminated by decapitation. The brains were fixed in 4% (vol/vol) paraformaldehyde solution overnight, and they were soaked in a refrigerated 30% (vol/vol) sucrose solution in 0.1 M PB. Whole brains were frozen in OCT compound (Miles) and sectioned transversely at 20-μ m thickness on a cryostat at -20 °C. After blocking nonspecific binding with 5% (vol/vol) normal goat serum and 1% BSA in PBS containing 0.5% Triton X-100, the sections were immersed overnight at 4 °C in 1:100 dilution of rabbit anti-salmon P450 7α antibody. The sections were then incubated for 60 min with Alexa Fluor 555 anti-rabbit IgG (Thermo Fisher Scientific) at a dilution of 1:1,000. After washing, the sections were mounted with mounting medium and visualized by using a fluorescence microscope (Leica). Double-labeling immunofluorescence for P450 7α and TH. Sections (20-μ m thickness) were incubated at 4 °C overnight with rabbit anti-salmon P450 7α antibody and mouse anti-TH antibody (MAB318, Merck Millipore) in blocking solution. Then, the sections were incubated with Alexa Fluor 555 goat anti-rabbit IgG (1:1,000; Thermo Fisher Scientific) and Alexa Fluor 488 goat anti-mouse IgG (1:1,000; Thermo Fisher Scientific) secondary antibodies for 1 h at room temperature. Digitized pictures of the same microscopic field were captured for the two Alexa Fluors.
Statistical analyses. Data were statistically analyzed with one-way ANOVA (when a normal distribution was found), and then Tukey-Kramer test was performed as a post hoc test. Student's t test was also conducted to analyze for significance when the experiment consisted of only two groups. The behavioral testing was analyzed by using a chi-square test of independence. Significant difference was set at P < 0.05.
